GOLDMAN SACHS GROUP INC - 30 Sep 2025 SCHEDULE 13G/A Report for SPRINGWORKS THERAPEUTICS, INC. Common Stock, par value $.0001 per share (SWTX)

Filing manager: GOLDMAN SACHS GROUP INC
Reporting owner: THE GOLDMAN SACHS GROUP, INC.
Security: SPRINGWORKS THERAPEUTICS, INC. Common Stock, par value $.0001 per share
Beneficially owned shares: 132 shares
Class ownership: 0%
Symbol: SWTX
Form type: SCHEDULE 13G/A
Accepted by SEC: 12 Nov 2025, 15:34:14 UTC
Event date: 30 Sep 2025
Previous filing: 13 Aug 2025
SEC filing: View on sec.gov

Key filing fact

GOLDMAN SACHS GROUP INC disclosed 0% ownership in SPRINGWORKS THERAPEUTICS, INC. Common Stock, par value $.0001 per share (SWTX) on 30 Sep 2025.

Key facts

GOLDMAN SACHS GROUP INC filed SCHEDULE 13G/A for SPRINGWORKS THERAPEUTICS, INC. Common Stock, par value $.0001 per share (SWTX).
Disclosed ownership: 0%.
Date of event: 30 Sep 2025.

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Reporting persons

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
THE GOLDMAN SACHS GROUP, INC.	0%	132	0	47	Name: Sam Prashanth	Attorney-in-fact
GOLDMAN SACHS & CO. LLC	0%	132	0	47	Name: Sam Prashanth	Attorney-in-fact

CIK / CUSIP context first

Broader feeds